UBS Group’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$541M Buy
1,646,714
+174,744
+12% +$62.7M 0.08% 252
2025
Q4
$517M Buy
1,471,970
+66,378
+5% +$24.2M 0.08% 223
2025
Q3
$520M Sell
1,405,592
-44,246
-3% -$17.1M 0.08% 226
2025
Q2
$574M Sell
1,449,838
-156,909
-10% -$58.7M 0.1% 198
2025
Q1
$598M Buy
1,606,747
+186,150
+13% +$70.8M 0.11% 181
2024
Q4
$511M Buy
1,420,597
+228,712
+19% +$84.7M 0.09% 190
2024
Q3
$431M Buy
1,191,885
+75,107
+7% +$25.9M 0.09% 204
2024
Q2
$380M Buy
1,116,778
+49,944
+5% +$16.9M 0.09% 206
2024
Q1
$382M Buy
1,066,834
+169,835
+19% +$57.1M 0.1% 203
2023
Q4
$269M Buy
896,999
+172,391
+24% +$48.4M 0.08% 244
2023
Q3
$198M Sell
724,608
-86,481
-11% -$24.8M 0.07% 291
2023
Q2
$247M Buy
811,089
+137,620
+20% +$39.8M 0.08% 247
2023
Q1
$192M Sell
673,469
-30,950
-4% -$8.21M 0.07% 267
2022
Q4
$172M Buy
704,419
+336,513
+91% +$76.4M 0.06% 316
2022
Q3
$74.5M Sell
367,906
-99,201
-21% -$20.9M 0.03% 530
2022
Q2
$92.9M Sell
467,107
-185,057
-28% -$43.5M 0.04% 475
2022
Q1
$174M Sell
652,164
-43,081
-6% -$11.1M 0.06% 338
2021
Q4
$186M Sell
695,245
-27,009
-4% -$7.09M 0.05% 367
2021
Q3
$190M Sell
722,254
-9,183
-1% -$2.46M 0.06% 316
2021
Q2
$190M Buy
731,437
+62,351
+9% +$15.9M 0.06% 312
2021
Q1
$163M Buy
669,086
+14,205
+2% +$3.41M 0.05% 332
2020
Q4
$160M Buy
654,881
+18,735
+3% +$4.24M 0.05% 331
2020
Q3
$133M Buy
636,146
+137,478
+28% +$26.7M 0.05% 327
2020
Q2
$89.9M Buy
498,668
+80,813
+19% +$14.9M 0.04% 404
2020
Q1
$69.6M Sell
417,855
-363,069
-46% -$70.9M 0.03% 445
2019
Q4
$164M Buy
780,924
+143,590
+23% +$29.8M 0.06% 302
2019
Q3
$138M Buy
637,334
+11,612
+2% +$2.49M 0.05% 322
2019
Q2
$129M Buy
625,722
+64,981
+12% +$12.4M 0.05% 333
2019
Q1
$111M Buy
560,741
+149,282
+36% +$26.9M 0.05% 366
2018
Q4
$64.5M Sell
411,459
-44,986
-10% -$7.52M 0.03% 485
2018
Q3
$81.1M Buy
456,445
+23,917
+6% +$4.08M 0.03% 475
2018
Q2
$73M Buy
432,528
+47,051
+12% +$7.91M 0.03% 504
2018
Q1
$62M Sell
385,477
-54,502
-12% -$8.78M 0.03% 540
2017
Q4
$68.1M Buy
439,979
+100,606
+30% +$15.4M 0.03% 549
2017
Q3
$48.2M Sell
339,373
-27,176
-7% -$3.9M 0.02% 609
2017
Q2
$50.9M Buy
366,549
+50,631
+16% +$6.95M 0.03% 560
2017
Q1
$41.6M Buy
315,918
+15,407
+5% +$1.95M 0.02% 625
2016
Q4
$36M Sell
300,511
-15,994
-5% -$1.84M 0.02% 692
2016
Q3
$36.8M Buy
316,505
+27,481
+10% +$3.2M 0.02% 644
2016
Q2
$34.6M Buy
289,024
+18,863
+7% +$2.11M 0.02% 652
2016
Q1
$29M Sell
270,161
-24,597
-8% -$2.42M 0.02% 682
2015
Q4
$27.4M Sell
294,758
-1,671
-0.6% -$160K 0.02% 780
2015
Q3
$27.9M Sell
296,429
-225,209
-43% -$22.3M 0.02% 714
2015
Q2
$49.9M Buy
521,638
+43,582
+9% +$4.13M 0.03% 521
2015
Q1
$44.1M Sell
478,056
-42,925
-8% -$4M 0.03% 560
2014
Q4
$49.1M Buy
+520,981
New +$46.2M 0.03% 543

Other funds holding SYK

UBS Group's SYK Position: Q1 2026 in Review

UBS Group increased its Stryker (SYK) stake by 12% in Q1 2026, buying an estimated $62.7M and bringing the position to 1,646,714 shares worth $541M. The position accounts for 0.08% of the portfolio, ranked #252.

UBS Group first reported a position in SYK in Q4 2014 and has held it in 46 quarters since. The position peaked at $598M in Q1 2025. 2,294 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • UBS Group held 1,646,714 shares of Stryker worth $541M as of Q1 2026.
  • UBS Group bought 174,744 Stryker shares in Q1 2026, an estimated $62.7M.
  • Stryker made up 0.08% of UBS Group's portfolio in Q1 2026, its #252 holding.
  • UBS Group first reported a position in Stryker in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Stryker position peaked at $598M in Q1 2025.
  • 2,294 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.